Anti–Saccharomyces cerevisiae IgA antibodies have been proposed as a serologic method for differentiating Crohn disease from ulcerative colitis, but they are neither adequately sensitive nor specific and can lead to false-positive results if used as part of the initial assessment for gastrointestinal symptoms. have been proposed as a serologic method for differentiating Crohn disease from ulcerative colitis, but they are neither adequately sensitive nor specific and can lead to false-positive results if used as part of the initial assessment for gastrointestinal symptoms.
from ACP MKSAP
Comment 0
| No. | Subject | Author | Date | Views |
|---|---|---|---|---|
| 9 | SLE workup | Drhyo | 2025.03.09 | 144 |
| 8 | myositis workup | Drhyo | 2025.03.20 | 133 |
| 7 | p vs c ANCA | Drhyo | 2025.06.08 | 142 |
| 6 | AS syndesmosohyte | Drhyo | 2025.08.15 | 75 |
| » | Anti–Saccharomyces cerevisiae IgA antibodies Crohn | Drhyo | 2025.08.19 | 82 |
| 4 | Marker for Myositis | Drhyo | 2025.08.22 | 84 |
| 3 | Antiphospholipid (low PL/Warfarin/SLE) | Drhyo | 2025.08.22 | 76 |
| 2 | Raynaud's phenomenon | Drhyo | 2026.01.19 | 18 |
| 1 | ESR | Drhyo | 2026.03.09 | 22 |